Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections - Schlicht, Kristina; Rohmann, Nathalie; Geisler, Corinna; Hollstein, Tim; Knappe, Carina; Hartmann, Katharina; Schwarz, Jeanette; Tran, Florian; Schunk, Domagoj; Junker, Ralf; Bahmer, Thomas; Rosenstiel, Philip; et al. (International Journal of Obesity, 2020)
Keywords: 13/1; 631/45/607; 692/499; 692/699/2743/137/773; 692/699/2743/393; 96/1; Aged; Betacoronavirus; Binding; Case-Control Studies; Comment; Coronavirus Infections - blood; Coronavirus Infections - epidemiology; Coronaviruses; COVID-19; Data points; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes therapy; Dipeptidyl Peptidase 4 - blood; Dipeptidyl-peptidase IV; Epidemiology; Female; Health aspects; Health Promotion and Disease Prevention; Hospitalization; Human subjects; Humans; Immune system; Infections; Internal Medicine; Internalization; Male; Medicine; Medicine & Public Health; Membranes; Metabolic Diseases; Metabolic disorders; Middle Aged; Obesity; Pandemics; Pneumonia, Viral - blood; Pneumonia, Viral - epidemiology; Proteases; Public Health; Risk analysis; Risk factors; SARS-CoV-2; Sepsis; Sepsis - blood; Sepsis - epidemiology; Type 2 diabetes; Viral diseases; Virus diseases; Viruses